Newshub18 :India will make monkeypox vaccine! WHO says the dosage will be 50 lakh to 1 crore.The Center on Wednesday (July 27) invited ‘Expression of Interest’ (EOIs) for the development of monkeypox virus vaccine. Four cases of monkeypox have been confirmed in India so far. Only then was this call made by the government. On the other hand, the head of the World Health Organization, Tedros Adhanom Ghebreyesus, said on the same day that at least 500,000 to 100,000,000 doses of the monkeypox vaccine are needed to protect the population who are at the highest risk of exposure to the virus. Incidentally, the smallpox vaccine has already been shown to be effective against monkeypox.
WHO director-general urged countries that have smallpox vaccine to share it with the rest of the world during monkeypox outbreaks. Earlier, the WHO had made a similar call for the coronavirus vaccine. But in the end, no country responded to that call.
On Wednesday, the Government of India sought EoIs from experienced vaccine manufacturers and in-vitro diagnostic kit manufacturers for joint collaboration in developing a vaccine against monkeypox disease. Besides, manufacturers of diagnostic kits have been directed to manufacture enough diagnostic kits to detect the disease. Last date for submission of expression of interest in this regard is 10th August.
The Indian Council of Medical Research (ICMR) said that they will provide the strain of monkeypox virus required by the vaccine manufacturers to make the vaccine. ICMR said in a statement that it wants to develop a vaccine and diagnostic kit for monkeypox virus. Research will be conducted in collaboration with vaccine manufacturers and diagnostic kit manufacturers. They are ready to enter into any kind of non-exclusive agreement for this. According to sources, even before the government’s call, several pharma companies have started discussions with the government to develop a possible monkeypox vaccine.
Among the monkeypox vaccines on the market, the safest is Genios Vaccine, manufactured by the Danish pharmaceutical company Bavarian Nordic. According to the company, US and European drug regulators have approved the use of vaccine doses made in their Danish factory. U.S. drug regulators claim that the approval will fill the current shortage of monkeypox vaccine in the United States. According to the World Health Organization, more than 18,000 cases of monkeypox have currently been reported from 78 countries around the world. Most are reported from European countries. Meanwhile, the World Health Organization has declared a state of emergency over the outbreak of monkeypox